Restrictive cardiomyopathy;Cardiomyopathies restrictives

Archives des Maladies du Coeur et des Vaisseaux

Volumn 91, Issue 12 SUPPL., 1998, Pages 59-64

  Langlard, J M ^a  

^a CHU de Nantes   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE; ANTICOAGULANT AGENT; DIGOXIN;

AMYLOIDOSIS; ANGINA PECTORIS; ATRIOVENTRICULAR BLOCK; COMPUTER ASSISTED TOMOGRAPHY; DISEASE ASSOCIATION; DOPPLER ECHOCARDIOGRAPHY; ENDOCARDIAL DISEASE; HEART ARRHYTHMIA; HEART CATHETERIZATION; HEART MUSCLE BIOPSY; HUMAN; IDIOPATHIC DISEASE; NUCLEAR MAGNETIC RESONANCE IMAGING; ORAL DRUG ADMINISTRATION; PERICARDIECTOMY; RESTRICTIVE CARDIOMYOPATHY; REVIEW;

CARDIOMYOPATHY, RESTRICTIVE; COMBINED MODALITY THERAPY; DIAGNOSIS, DIFFERENTIAL; GENETIC PREDISPOSITION TO DISEASE; HEART TRANSPLANTATION; HUMANS; PROGNOSIS;

EID: 0032411298     PISSN: 00039683     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (27)

1. Report of the 1995 World Health Organization/International Society and Federation of Cardiology. Task Force on the definition and classification of cardiomyopathies. Circulation 1996 ; 93 : 841-2.
2. Bouhour JB, Desnos M, Komajda M, Sacrez A. Définitions et classification des cardiomyopathies. Arch Mal Cœur 1996 ; 89 : 815-7.
3. Maisch B, Brilla C. Restrictive cardiomyopathy. Current Opinion in Cardiology 1993 ; 8 : 447-53.
4. Delpech M. Des protéines amyloïdes aux amyloses. Rev Prat (Paris) 1997 ; 47 : 1761-6.
5. Aroney C, Bett N, Radford D. Familial restrictive cardiomyopathy. Aust N Z J Med 1988 ; 18 : 877-8.
6. Katritsis D, Wilmshurst PT, Wenden JA, Davies MJ, Webb-Peploe MM. Primary restrictive cardiomyopathy: clinical and pathologic characteristics. J Am Coll Cardiol 1991 ; 18 : 1230-5.
7. Fitzpatrick AP, Shapiro LM, Rickards AF, Poole-Wilson PA. Familial restrictive cardiomyopathy with atrioventricular block and skeletal myopathy. Br Heart J 1990 ; 63 : 114-8.
8. Arbustini E, Morbini P. Grosso M et al. Restrictive cardiomyopathy, atrioventricular block and mild to subclinical myopathy in patients with desmin-immunoreactive material deposits. J Am Coll Cardiol 1998 ; 31 : 645-53.
9. Hirota Y, Shimizu G, Kita Y et al. Spectrum of restrictive cardiomyopathy : report of the national survey in Japan. Am Heart J 1990 ; 120 : 188-94.
10. McKenna WJ, Stewart JT, Nihoyannopoulos P. McGinty F, Davies MJ. Hypertrophic cardiomyopathy without hypertrophy : two families with myocardial disarray in the absence of increased myocardial mass. Br Heart J 1990 ; 63 : 287-90.
11. Angelini A, Calzolari V, Thiene G et al. Morphologic spectrum of primary restrictive cardiomyopathy. Am J Cardiol 1997 ; 80 : 1046-50.
12. Wynne J, Braunwald E. The cardiomyopathies and myocarditides. In : Braunwald E (ed). Heart disease. 5th edition. Philadelphia : W.B. Sounders Company, 1997 : 1429.
13. Dubrey SW, Cha K, Anderson J et al. The clinical features of immunoglobulin light-chain (AL) amyloidosis with heart involvement. QJM 1998 ; 91 : 141-57.
14. Keren A, Popp RL Assignment of patients into the classification of cardiomyopathies. Circulation 1992 ; 86 : 1622-33.
15. Kushwaha SS, Fallon JT, Fuster V. Restrictive cardiomyopathy. N Engl J Med 1997 ; 336 : 267-76.
16. Lewis AB. Clinical profile and outcome of restrictive cardiomyopathy in children. Am Heart J 1992 ; 123 : 1589-93.
17. Cetta F, O'Leary PW, Seward JB. Driscoll DJ. Idiopathic restrictive cardiomyopathy in childhood : diagnostic features and clinical course. Mayo Clin Proc 1995 ; 70 : 634-40.
18. Kyle RA, Gertz MA, Greipp PR et al. A trial of three regimens for primary amyloidosis: colchicine alone, melphalan ana prednisone, and melphalan, prednisone, and colchicine. N Engl J Med 1997 ; 336 : 1202-7.
19. Chamarthi B, Dubrey SW, Cha K, Skinner M, Falk RH. Features and prognosis of exertional syncope in light-chain associated AL cardiac amyloidosis. Am J Cardiol 1997 ; 80 : 1242-5.
20. Cuerto-Garcia L, Reeder GS, Kyle RA et al. Echocardiographic findings in systemic amyloidosis : spectrum of cardiac involvement and relation to survival. J Am Coll Cardiol 1985 ; 6 : 737-43.
21. Patel AR, Dubrey SW, Mendes LA et al. Right ventricular dilation in primary amyloidosis : an independent predictor of survival. Am J Cardiol 1997 ; 80 : 486-92.
22. Klein AL, Hatle LK, Talierco CP et al. Prognostic significance of Doppler measures of diastolic function in cardiac amyloidosis. A Doppler echocardiography study. Circulation 1991 ; 83 : 808-16.
23. Mathew V, Chaliki H, Nishimura RA. Atrioventricular sequential pacing in cardiac amyloidosis : an acute Doppler echocardiographic and cathetenzation hemodynamic study. Clin Cardiol 1997 ; 20 : 723-5.
24. Pelosi F, Capehart J, Roberts WC. Effectiveness of cardiac transplantation for primary (AL) cardiac amyloidosis. Am J Cardiol 1997 ; 79 : 532-5.
25. SFC. Recommandations de la Société française de cardiologie pour l'inscription d'adultes, hors urgence, sur une liste d'attente en vue d'une transplantation cardiaque. Arch Mal Cœur 1997 ; 90 : 1437-42.
26. Hosenpud JD, DeMarco T, Frazier OH et al. Progression of systemic disease and reduced long-term survival in patients with cardiac amyloidosis undergoing heart transplantation. Circulation 1991 ; 84 (suppl III) : in 338-III 343.
27. Comenzo RL, Vosburgh E, Falk RH et al. Dose-intensive melphalan with blood stem-cell support for the treatment of AL (Amyloid light-chain) amyloidosis : survival and responses in 25 patients. Blood 1998 ; 91 : 3662-70.